All In Biotech

Drug Trial Radar · NCT00494507

Hyper- and Hypokalemic Periodic Paralysis Study

Dichlorphenamide vs. Placebo for Periodic Paralysis

Last checked: Nov 20, 2026Latest source record: Jun 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

71

Actual

Start

Jun 2007

Primary completion

Apr 2013

Study completion May 2013

Sponsor

Lead sponsor
University of RochesterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Jun 29, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.

Conditions

  • Hyperkalemic Periodic Paralysis
  • Hypokalemic Periodic Paralysis

Interventions

  • Dichlorphenamide (double-blind)Drug

    50mg tablet; maximum dosage 400mg/day

  • Placebo (double-blind)Drug

    Inactive substance manufactured to look like Dichlorphenamide 50mg tablet

  • Dichlorphenamide (open-label)Drug

    50mg tablet; maximum dosage 400mg/day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HYP Attack RateTime frame: 8 weeks
  2. HOP Attack RateTime frame: 8 weeks

Locations

12 sites in 3 countries. Site status is shown where the registry gives one.

  • UCLA Neurology

    Los Angeles, California

  • University of California-San Francisco

    San Francisco, California

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Brigham & Women's Hospital

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Columbia University Medical Center

    New York, New York

  • University of Rochester

    Rochester, New York

  • Ohio State University

    Columbus, Ohio

  • University of Texas Southwestern-Dallas

    Dallas, Texas

  • University of Milan

    San Donato, Milan, Italy

  • Institute of Neurology-Queen's Square

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.